New User:

-or-
Username:
Password:
Forgot your password?

Stock Market & Financial Investment News

News Breaks
November 5, 2012
06:59 EDTDNDNDendreon price target lowered to $4 from $5 at William Blair
William Blair lowered its price target for Dendreon after the company's Q3 Provenge sales missed expectations. The firm expects sales of the drug to remain challenged and keeps an Underperform rating on the stock.
News For DNDN From The Last 14 Days
Sign up for a free trial to see the rest of the stories you've been missing.
October 2, 2014
06:37 EDTDNDNDendreon price target lowered to $1 from $2 at Citigroup
Subscribe for More Information

Sign up for a free trial to see the rest of the stories you've been missing.

I agree to the theflyonthewall.com disclaimer & terms of use